Live from the NIH registry
Studies recruiting near Sunnyvale right now
Top 25 of 1,157 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Sutter Palo Alto Medical Foundation: Sunnyvale — Sunnyvale, California (1.2 mi)
· Sponsor: American Society of Clinical Oncology
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
Stanford University: Stanford Children's Health — Redwood City, California (13.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
Drug Resistant Epilepsy, Epilepsy
Phase 1, Phase 2
Interventional 8 participants sought
Stanford University School of Medicine — Palo Alto, California (7.6 mi)
· Sponsor: NaviFUS Corporation
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California (7.6 mi)
· Sponsor: VA Office of Research and Development
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
NorCal Endocrinology and Internal Medicine — San Ramon, California (27.5 mi)
· Sponsor: Novo Nordisk A/S
SWIR Otoscopy Study
Otitis Media, Otitis Media Chronic
N/A
Interventional 100 participants sought
Stanford University — Palo Alto, California (7.6 mi)
· Sponsor: Stanford University
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Stanford Women's Cancer Center — Palo Alto, California (7.6 mi)
· Sponsor: Relay Therapeutics, Inc.
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
Stanford University — Stanford, California (8.2 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Stanford University Medical Center — Stanford, California (8.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Palo Alto Medical Foundation-Sunnyvale — Sunnyvale, California (1.2 mi)
· Sponsor: SWOG Cancer Research Network
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Chronic Low Back Pain
N/A
Interventional 2,529 participants sought
VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California (7.6 mi)
· Sponsor: VA Office of Research and Development
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Stanford Hospitals and Clinics — Stanford, California (8.2 mi)
· Sponsor: Cook Research Incorporated
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Lucile Packard Children's Hospital Stanford University — Palo Alto, California (7.6 mi)
· Sponsor: National Cancer Institute (NCI)
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
Heart Failure Congenital, Single-ventricle
N/A
Interventional 50 participants sought
Stanford University — Stanford, California (8.2 mi)
· Sponsor: Stanford University
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
IBS - Irritable Bowel Syndrome, Healthy
N/A
Observational 40 participants sought
Stanford Digestive Health Clinic — Redwood City, California (13.5 mi)
· Sponsor: Stanford University
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
Board of Trustees of the Leland Stanford Junior University — Stanford, California (8.2 mi)
· Sponsor: Stanford University
Prehabilitation and Rehabilitation in PAD
Peripheral Arterial Disease
N/A
Interventional 300 participants sought
VA Palo Alto Health Care System — Palo Alto, California (7.6 mi)
· Sponsor: Palo Alto Veterans Institute for Research
Nutrition OUtReach In Systems of Healthcare
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant
N/A
Interventional 210 participants sought
Stanford University — Stanford, California (8.2 mi)
· Sponsor: University of Kansas Medical Center
A Study of Esomeprazole in Children With Autism
Autism, Autism Spectrum Disorder
Phase 2
Interventional 25 participants sought
Stanford University School of Medicine — Stanford, California (8.2 mi)
· Sponsor: Stanford University
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Epic Care-Dublin — Dublin, California (22.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney Disease, Proteinuria
Phase 3
Interventional 100 participants sought
Lucille Packard Children's Hospital Stanford - Pediatric Nephrology — Palo Alto, California (7.6 mi)
· Sponsor: Bayer
A Retrospective Study to Characterize Participants With Propionic Acidemia
Propionic Acidemia
N/A
Observational 60 participants sought
University of Stanford Medical Center — Stanford, California (8.2 mi)
· Sponsor: ModernaTX, Inc.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Palo Alto Medical Foundation Research Center — Palo Alto, California (7.6 mi)
· Sponsor: Hoffmann-La Roche
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Mills Peninsula Medical Center — Burlingame, California (23.3 mi)
· Sponsor: Joseph Broderick, MD
Phase 1 Study of C.001 in Retinal Degeneration
Geographic Atrophy, Stargardt Disease
Phase 1
Interventional 15 participants sought
Palo Alto Medical Foundation — Palo Alto, California (7.6 mi)
· Sponsor: Cellio Therapeutics Inc